FDA Identifies Safety Issue with Carboplatin Dosing

Doctor's Guide -- ROCKVILLE, Md -- October 8, 2010 -- The US Food and Drug Administration (FDA) is informing members of the oncology community of recent changes in the measurement of serum creatinine which may have an impact on carboplatin dosing.